Currently, the share price for Marksans Pharma Ltd. is delayed. Login to view live prices.
Marksans Pharma Ltd.
0.00 (0.00%) 1D
- Prev. Close159.65
- Upper Circuit191.55
- Lower Circuit127.75
Analyst Recommendations For Marksans Pharma Ltd.
As recommended by 2 analysts
Marksans Pharma Ltd.'s Info & Management
Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.
- Chief Financial OfficerJitendra Sharma
- Senior Vice President(QC)Mr. Sunil K Rane
- Director(Quality)Mr. Harish Vyas
- Senior General ManagerMr. Manda Murali Bhaskar Rao
- General Manager(International Business)Ms. Ashwini Memane
- General ManagerMr. Piyush Joshi
FAQs on Marksans Pharma Ltd.
What is the share price of Marksans Pharma Ltd.?
Marksans Pharma Ltd. share price is ₹158.85 as of November 30, 2023, 09:30 AM. Share prices change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the market cap of Marksans Pharma Ltd.?
Market cap is calculated by multiplying the company's share price with the total outstanding shares. The market cap of Marksans Pharma Ltd. is ₹7,235 Cr as of November 30, 2023.
What is the PE ratio of Marksans Pharma Ltd.?
The PE ratio of Marksans Pharma Ltd. is 24.30 as of November 30, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).
What is the PB ratio of Marksans Pharma Ltd.?
The trailing twelve month (TTM) PB ratio of Marksans Pharma Ltd. is 4.10 as of November 30, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Marksans Pharma Ltd.?
Upper Circuit is ₹191.55. Lower Circuit is ₹127.75.
What is the ROE of Marksans Pharma Ltd.?
Marksans Pharma Ltd. reported an ROE of 15.25% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Marksans Pharma Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Marksans Pharma Ltd., Promoter held 43.8%, the FII held 15.1%, DII held 4% and the public held 37.1% of the total shares.
How to buy Marksans Pharma Ltd. Share?
What is the fair value of Marksans Pharma Ltd.?
Fair value in investing refers to the estimated potential price of the business. The market (or exchange) is expected to determine the fair value of listed companies by the way of demand and supply. To determine the fair value of Marksans Pharma Ltd. as per market, look at the current bid and ask prices during the trading hours.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.